OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pregnancy-related adverse events associated with statins: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System (FAERS)
Tingxi Wu, Yanfeng Shi, Bin Zhu, et al.
Expert Opinion on Drug Safety (2023) Vol. 23, Iss. 3, pp. 313-321
Closed Access | Times Cited: 13
Tingxi Wu, Yanfeng Shi, Bin Zhu, et al.
Expert Opinion on Drug Safety (2023) Vol. 23, Iss. 3, pp. 313-321
Closed Access | Times Cited: 13
Showing 13 citing articles:
Dyslipidaemia management in pregnant patients: a 2024 update
Joanna Lewek, Agata Bielecka‐Dąbrowa, Peter P. Tóth, et al.
European Heart Journal Open (2024) Vol. 4, Iss. 3
Open Access | Times Cited: 9
Joanna Lewek, Agata Bielecka‐Dąbrowa, Peter P. Tóth, et al.
European Heart Journal Open (2024) Vol. 4, Iss. 3
Open Access | Times Cited: 9
Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) data from 2004 to 2023
Yihan Yang, Sheng Wei, Huan Tian, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Yihan Yang, Sheng Wei, Huan Tian, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Statins for preventing preeclampsia
Themistoklis Paraskevas, Georgios Gakis, Michail Papapanou, et al.
Cochrane library (2025) Vol. 2025, Iss. 3
Closed Access
Themistoklis Paraskevas, Georgios Gakis, Michail Papapanou, et al.
Cochrane library (2025) Vol. 2025, Iss. 3
Closed Access
Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
Xiaoling Zhong, Yihan Yang, Sheng Wei, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0309849-e0309849
Open Access
Xiaoling Zhong, Yihan Yang, Sheng Wei, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0309849-e0309849
Open Access
Genetic Counseling and Genetic Testing for Familial Hypercholesterolemia
Hayato Tada, Masa‐aki Kawashiri, Atsushi Nohara, et al.
Genes (2024) Vol. 15, Iss. 3, pp. 297-297
Open Access | Times Cited: 3
Hayato Tada, Masa‐aki Kawashiri, Atsushi Nohara, et al.
Genes (2024) Vol. 15, Iss. 3, pp. 297-297
Open Access | Times Cited: 3
Characteristics, Physiopathology and Management of Dyslipidemias in Pregnancy: A Narrative Review
Elena Formisano, E. Proietti, Giuseppina Perrone, et al.
Nutrients (2024) Vol. 16, Iss. 17, pp. 2927-2927
Open Access | Times Cited: 3
Elena Formisano, E. Proietti, Giuseppina Perrone, et al.
Nutrients (2024) Vol. 16, Iss. 17, pp. 2927-2927
Open Access | Times Cited: 3
A safety signal for congenital strabismus associated with valproic acid: A pharmacovigilance analysis utilizing the FDA Adverse Event Reporting System database
Yuichi Uwai, Tomohiro Nabekura
Congenital Anomalies (2024) Vol. 64, Iss. 5, pp. 207-214
Closed Access | Times Cited: 1
Yuichi Uwai, Tomohiro Nabekura
Congenital Anomalies (2024) Vol. 64, Iss. 5, pp. 207-214
Closed Access | Times Cited: 1
Role of Statins in Oral and Maxillofacial Surgery: A Literature Review
S. Kanabar, Deepankar Shukla, Nitin Bhola, et al.
Cureus (2024)
Open Access | Times Cited: 1
S. Kanabar, Deepankar Shukla, Nitin Bhola, et al.
Cureus (2024)
Open Access | Times Cited: 1
The safety profile of usage of glucagon‐like peptide‐1 receptor agonists in pregnancy: A pharmacovigilance analysis based on the Food and Drug Administration Adverse Event Reporting System
Jianxing Zhou, Zipeng Wei, Weipeng Lai, et al.
British Journal of Clinical Pharmacology (2024)
Closed Access | Times Cited: 1
Jianxing Zhou, Zipeng Wei, Weipeng Lai, et al.
British Journal of Clinical Pharmacology (2024)
Closed Access | Times Cited: 1
Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
Xiaoling Zhong, Yihan Yang, Sheng Wei, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Xiaoling Zhong, Yihan Yang, Sheng Wei, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Risk of adverse pregnancy outcomes and impact of statin use in pregnant women with familial hypercholesterolemia
Karianne Svendsen, Jacob J. Christensen, Jannicke Igland, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Karianne Svendsen, Jacob J. Christensen, Jannicke Igland, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Pregnancy related adverse events and congenital disorders associated with fluoroquinolones: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System (FAERS)
Daochun Xiang, Wen-Long Xie, Gang-Ying Cheng, et al.
Heliyon (2024), pp. e37547-e37547
Open Access
Daochun Xiang, Wen-Long Xie, Gang-Ying Cheng, et al.
Heliyon (2024), pp. e37547-e37547
Open Access
The quantity, reliability, transparency, reporting, and interpretation of pharmacovigilance signal detection studies in pregnancy: a meta-epidemiological study
Xue‐Feng Jiao, Zhengyang Zhang, Liqing Gong, et al.
European Journal of Clinical Pharmacology (2024) Vol. 81, Iss. 2, pp. 309-319
Closed Access
Xue‐Feng Jiao, Zhengyang Zhang, Liqing Gong, et al.
European Journal of Clinical Pharmacology (2024) Vol. 81, Iss. 2, pp. 309-319
Closed Access
